Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1951 6
1952 10
1953 10
1954 7
1955 8
1956 5
1957 2
1958 11
1959 7
1960 9
1961 5
1962 4
1963 2
1964 10
1965 16
1966 9
1967 13
1968 7
1969 9
1970 9
1971 6
1972 7
1973 4
1974 7
1975 13
1976 13
1977 12
1978 8
1979 9
1980 7
1981 8
1982 6
1983 3
1985 4
1986 3
1988 1
1989 3
1990 2
1991 4
1992 2
1993 4
1994 5
1995 1
1997 1
1998 1
1999 1
2001 1
2003 1
2004 3
2005 5
2006 6
2007 8
2008 13
2009 9
2010 6
2011 14
2012 11
2013 26
2014 25
2015 14
2016 18
2017 9
2018 8
2019 12
2020 11
2021 6
2022 2
2023 2
2024 5
2025 0

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

476 results

Results by year

Filters applied: . Clear all
Page 1
Patient-Reported Outcomes in Patients With Advanced Urothelial Cancer Who Are Ineligible for Cisplatin and Treated With First-Line Enfortumab Vedotin Alone or With Pembrolizumab.
Milowsky MI, O'Donnell PH, Hoimes CJ, Petrylak DP, Flaig TW, Moon HH, Friedlander TW, Mar N, McKay RR, Srinivas S, Gravis G, Ramamurthy C, Bupathi M, Bracarda S, Wright P, Hepp Z, Carret AS, Yu Y, Dillon R, Kataria R, Beaumont JL, Purnajo I, Rosenberg JE. Milowsky MI, et al. Among authors: beaumont jl. J Clin Oncol. 2024 Apr 20;42(12):1403-1414. doi: 10.1200/JCO.23.01547. Epub 2024 Jan 12. J Clin Oncol. 2024. PMID: 38215355 Free PMC article. Clinical Trial.
What Else Can We Do to Ensure Transplant Equity for High-Risk Patients?
Waterman AD, Beaumont JL. Waterman AD, et al. Among authors: beaumont jl. Clin J Am Soc Nephrol. 2018 Apr 6;13(4):529-530. doi: 10.2215/CJN.02120218. Epub 2018 Mar 26. Clin J Am Soc Nephrol. 2018. PMID: 29581106 Free PMC article. No abstract available.
Autoimmune hyperlipidemia.
Beaumont JL, Beaumont V. Beaumont JL, et al. Atherosclerosis. 1977 Apr;26(4):405-18. doi: 10.1016/0021-9150(77)90111-3. Atherosclerosis. 1977. PMID: 67846 No abstract available.
Deucravacitinib Improves Patient-Reported Outcomes in Patients with Moderate to Severe Psoriasis: Results from the Phase 3 Randomized POETYK PSO-1 and PSO-2 Trials.
Armstrong AW, Augustin M, Beaumont JL, Pham TP, Hudgens S, Gordon KB, Zhuo J, Becker B, Zhong Y, Kisa RM, Banerjee S, Papp KA. Armstrong AW, et al. Among authors: beaumont jl. Dermatol Ther (Heidelb). 2024 Aug;14(8):2235-2248. doi: 10.1007/s13555-024-01224-x. Epub 2024 Jul 30. Dermatol Ther (Heidelb). 2024. PMID: 39080153 Free PMC article.
The impact of clinical and sociodemographic features on quality of life in patients with early stage cancers using the Functional Assessment of Cancer Therapy-General assessment tool.
Popovic M, Lao N, Zeng L, Zhang L, Cella D, Beaumont JL, Chow R, Chiu N, Chiu L, Lam H, Poon M, Chow E. Popovic M, et al. Among authors: beaumont jl. Support Care Cancer. 2013 Aug;21(8):2267-77. doi: 10.1007/s00520-013-1789-4. Epub 2013 Mar 22. Support Care Cancer. 2013. PMID: 23519569 Review.
476 results